CPIG
UNCY icon

Chicago Partners Investment Group’s Unicycive Therapeutics UNCY Stock Holding History

Chicago Partners Investment Group’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Sell
21,410
-368
-2% -$2.71K ﹤0.01% 1470
2026
Q1 		$168K Sell
21,778
-635
-3% -$4.16K ﹤0.01% 1363
2025
Q4 		$155K Sell
22,413
-4,548
-17% -$24.3K ﹤0.01% 1251
2025
Q3 		$127K Buy
+26,961
New +$118K ﹤0.01% 1182

Other funds holding UNCY

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

Chicago Partners Investment Group's UNCY Position: Q2 2026 in Review

Chicago Partners Investment Group reduced its Unicycive Therapeutics (UNCY) stake by 1.7% in Q2 2026, selling an estimated $2.71K and leaving 21,410 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #1470.

Chicago Partners Investment Group first reported a position in UNCY in Q3 2025 and has held it in 4 quarters since. The position peaked at $168K in Q1 2026. 11 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.

  • Chicago Partners Investment Group held 21,410 shares of Unicycive Therapeutics worth $117K as of Q2 2026.
  • Chicago Partners Investment Group sold 368 Unicycive Therapeutics shares in Q2 2026, an estimated $2.71K.
  • Unicycive Therapeutics made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1470 holding.
  • Chicago Partners Investment Group first reported a position in Unicycive Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Chicago Partners Investment Group's Unicycive Therapeutics position peaked at $168K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.